S-1MEF - Aptose Biosciences Inc. (0000882361) (Filer)

1 min to read

S-1MEF – Aptose Biosciences Inc. (0000882361) (Filer)

Filed: 2024-01-25 AccNo: 0001193125-24-015759 Size: 123 KB
Source: S-1MEF – Aptose Biosciences Inc. (0000882361) (Filer)

Linkers Industries Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq

New York, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Linkers Industries Limited (Nasdaq: LNKS) (the “Company”), a manufacturer and a supplier...
Insight Acquisition Corp Stockholders Approve Extension of Business Combination Period Through March 7, 2025

NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Insight Acquisition Corp. (NASDAQ: INAQ) announced today that its stockholders have approved...
Trends in Cayman Islands Companies listing on the NYSE and Nasdaq

The Cayman Islands is the most common non-US jurisdiction for listed entities - Entities established in 47 different jurisdictions are...
Shepherd Ave Capital Acquisition Corp Announces Closing of Initial Public Offering

Wilmington, DE, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Shepherd Ave Capital Acquisition Corporation (NASDAQ: SPHAU) (“SPHA” or the “Company”) announced...
“Outspoken critic” and former SEC Commissioner Paul Atkins to be nominated as SEC Chair

As widely reported, former SEC Commissioner Paul Atkins (2002-2008) is to be nominated to serve as SEC Chair. This WSJ...